CTOs on the Move

American Hospital Service Group

www.ahsg.us

 
American Hospital Service Group is a Exton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.ahsg.us
  • 415 Eagleview Blvd Ste 108
    Exton, PA USA 19341
  • Phone: 610.524.2400

Executives

Name Title Contact Details

Similar Companies

Pinecrest Community

Pinecrest Community is a Mount Morris, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Procured Health

Procured is a leading provider of technology driven solutions that optimize clinical resource management and transform supply chain into a strategic asset. High performing health systems and hospitals rely on Procured`s medical device research to make purchasing decisions on a daily basis.

Herbalife Nutrition

Herbalife Nutrition is a global company that has been changing people`s lives with great nutrition products and a proven business opportunity for its independent distributors since 1980. The Company offers high-quality, science-backed products, sold in over 90 countries by entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle. We have over 9,500 employees worldwide and are traded on the New York Stock Exchange (NYSE: HLF) with net sales of approximately $4.9 billion in 2019. To learn more, visit Herbalife.com or IAmHerbalife.com. Financial information is available on ir.herbalife.com We are also proud to sponsor more than 190 world-class athletes, teams and events around the globe, including Cristiano Ronaldo, the LA Galaxy, and numerous Olympic teams. Through our global campaign to eradicate hunger, we are committed to bringing nutrition and education to communities around the world.

Ampio Pharmaceuticals

Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates.  These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending.  Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™.  The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee.  Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema.  Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.

Sampling Technologies - STI Smart Technologies

Sampling Technologies - STI Smart Technologies is a Lower Sackville, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.